Order results by:
Issue | Title | |
Vol 18, No 2 (2025) | Pharmacoeconomic study of oral anticancer therapy: results of combined ABC/VEN and frequency analysis | Abstract similar documents |
J. A. Agafonova | ||
"... in 2022. The distribution of regimens by VEN groups was consistent with recommendations: 149 regimens (60 ..." | ||
Vol 8, No 4 (2015) | ABC-, VEN- AND FREQUENCY ANALYSIS OF TREATMENT OF ATRIAL FIBRILLATION IN OUTCOME PATIENTS | Abstract similar documents |
A. N. Korobeynikova, S. V. Malchikova | ||
"... and identify ways to optimize the consumption of medications. The objective of investigation is to hold ABC ..." | ||
Vol 12, No 4 (2019) | Clinical and economic analysis of drug costs in a general hospital in 2014-2018 | Abstract similar documents |
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova | ||
"... between various groups of drugs. Conclusion. The simultaneous use of the ABC/VEN and ATС/DDD analyzes ..." | ||
Vol 7, No 1 (2014) | ABC END VEN ANALYSYS OF COSTS FOR MEDICINE SAND MEDICAL TREATMENT COSTS PATIENT | Abstract similar documents |
M. A. Shapovalova, L. R. Koretskaya | ||
"... in Health Departmental Hospital station Astrahan 1 «Russian Railways», we carried out ABC and VEN analysis ..." | ||
Vol 15, No 1 (2022) | Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution | Abstract similar documents |
O. V. Zhukova, O. V. Ruina, M. V. Khazov, T. M. Konyshkina, E. A. Rodin, D. K. Lipatov | ||
"... for the reporting period of 2017–2018. We used the tools of ABC/VEN analysis and import substitution assessment ..." | ||
Vol 17, No 4 (2024) | The joint use of ABC/VEN analysis and the Beers criteria for optimizing expenditure of funds and rational prescribing of medications to elderly patients | Abstract similar documents |
O. A. Makhmudova, G. F. Avkhadieva, O. G. Bagdanova, V. N. Khaziakhmetova | ||
"... –2021 period. We conducted an integrated study combining ABC/VEN analysis and the Beers criteria ..." | ||
Vol 9, No 4 (2016) | PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION | Abstract similar documents |
D. S. Kaskaeva, M. M. Petrova, O. V. Zimnitskaya | ||
"... of combinations of drugs olmesartan/lercanidipine and zofenopril/lercanidipine. An ABC/VEN-analysis, сost ..." | ||
Vol 9, No 2 (2016) | EVALUATION OF RATIONALITY OF EXPENSES ON TREATMENT OF SEVERE COMMUNITY-ACQUIRES PNEUMONIA IN MULTI-PROFILE HOSPITAL | Abstract similar documents |
I. V. Demko, N. V. Gordeeva, E. N. Bochanova, N. I. Golovina, A. Yu. Kraposhina, I. A. Soloveva, E. A. Sobko, T. V. Gaygolnik, S. V. Chubarova | ||
"... to the ABC/VEN analysis during the period from 2004 till 2014 we found positive dynamics of increase ..." | ||
Vol 14, No 3 (2021) | Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital | Abstract similar documents |
L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva | ||
"... expenditure was carried out using ABC/VEN analysis. Results. The total expenditure on the procurement ..." | ||
Vol 9, No 2 (2016) | PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION | Abstract similar documents |
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva | ||
"... of International unlicensed name the necessary of which is in doubt. Conclusion. The ABC/ VEN analysis showed ..." | ||
Vol 9, No 2 (2016) | PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS | Abstract similar documents |
E. E. Vidyakina, S. V. Malchikova | ||
"... records of the patient, the analysis of cost of illness, ABC VEN — analysis. Results. The results of АВС ..." | ||
Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
"... ) in adults were published that did not contain interferon drug therapy regimens. Current therapy of chronic ..." | ||
Vol 12, No 3 (2019) | Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings | Abstract similar documents |
O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev | ||
"... an insignificant part (i.e., group C according to the ABC analysis). Notably, amikacin is prescribed more often ..." | ||
Vol 10, No 3 (2017) | ABC-analysis of pharmacotherapy in children hospitalized with bronchial asthma exacerbations | Abstract similar documents |
O. V. Zhukova, S. V. Kononova | ||
"... of pharmacotherapy was carried out in accordance with the ABC guidelines for an international non-proprietary name ..." | ||
Vol 16, No 2 (2023) | Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic | Abstract similar documents |
Yu. Sh. Gushchina, А. Yu. Abramov, Y. J. Haitham | ||
"... funding in the Syrian Arab Republic (SAR), pharmacoeconomic study of antiretroviral therapy (ART) regimens ..." | ||
Vol 14, No 2 (2021) | Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting | Abstract similar documents |
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov | ||
"... regimens with centralized purchases and the cost of targeted drugs per hospitalization case were calculated ..." | ||
Vol 11, No 2 (2018) | Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations | Abstract similar documents |
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov | ||
"... The existing model of financial support of medical assistance for clinical-statistical groups (CSGs ..." | ||
Vol 15, No 3 (2022) | Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis | Abstract similar documents |
А. V. Kukurika | ||
"... drug-resistant tuberculosis (MDR/XDR-TB) chemotherapy regimens. Material and methods. An analysis ..." | ||
Vol 16, No 2 (2023) | Pharmacoepidemiological and drug interaction analysis in the treatment of chronic renal and hepatic failure | Abstract similar documents |
O. V. Zhukova, D. S. Fokina, O. V. Ruina, M. V. Khazov | ||
"... ” was calculated using DDD per 100 bed-days. ABC analysis was used to estimate the costs of drug groups in therapy ..." | ||
Vol 14, No 2 (2021) | Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region | Abstract similar documents |
A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin | ||
"... drugs (bDMDs) within the constraints of diagnosis-related groups (DRGs) on the level of the Moscow ..." | ||
Vol 16, No 2 (2023) | Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance | Abstract similar documents |
N. Yu. Nikolenko, D. A. Kudlay, S. E. Borisov, T. E. Sannikova, N. P. Doktorova | ||
"... that 68.4% of patients in the group with bedaquiline-containing chemotherapy regimens reached the outcome ..." | ||
Vol 6, No 4 (2013) | Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia | Abstract similar documents |
R. I. Yagudina, I. Yu. Zinchuk | ||
"... » and «AICC + Eptacog alfa» schemes respectively. It is determined that the regimen «AICC + Eptacog alfa ..." | ||
Vol 7, No 2 (2014) | ANALYSIS OF DRUG PRODUCTS ASSORTMENT ACQUIRABLE BY HEALTHCARE ORGANIZATIONS FOR MEDICAL TREATMENT IN HOSPITAL SETTINGS WAS CONDUCTED | Abstract similar documents |
M. G. Malaev | ||
Vol 12, No 3 (2019) | Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 | Abstract similar documents |
D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh | ||
"... The article addresses the model of diagnosis-related groups (DRG) updated according to the new ..." | ||
Vol 12, No 1 (2019) | Evaluation of the clinical efficacy of anti-asthma pharmacotherapy in children using the software package based on the Fishburn method | Abstract similar documents |
O. V. Zhukova, I. V. Nikiforova | ||
"... Aim: to assess the clinical efficacy of pharmacotherapy regimens using a software package ..." | ||
Vol 17, No 3 (2024) | Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences | Abstract similar documents |
E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov | ||
"... Objective: to assess the demand for pharmacotherapy in risk groups on adverse cardiovascular (CV ..." | ||
Vol 17, No 4 (2024) | Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis | Abstract similar documents |
J. A. Agafonova, V. V. Omelyanovskiy | ||
"... into three groups: regimens with only oral administration, including combinations of multiple oral drugs ..." | ||
Vol 10, No 2 (2017) | CLINICAL AND ECONOMIC EVALUATION OF CHRONIC DISEASE TREATMENT: A DISCREPANCY BETWEEN THE TRADITIONAL PHARMACOECONOMIC AND SOCIO-ECONOMIC ANALYSES | Abstract similar documents |
O. V. Zhukova, S. V. Kononova | ||
"... -effectiveness” method) and socio-economic analysis of pharmaco-therapeutic regimens in a chronic disease ..." | ||
Vol 12, No 3 (2019) | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support | Abstract similar documents |
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov | ||
"... Clinical / Economic Analysis and the common ABC / VEN analysis are currently used to estimate ..." | ||
Vol 13, No 3 (2020) | The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups | Abstract similar documents |
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan | ||
"... Diagnosis-Related Groups (DRG) for the payment for biological therapy were created at the stage ..." | ||
Vol 15, No 4 (2022) | Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention | Abstract similar documents |
V. А. Ryagina, К. I. Matrenin, D. G. Shchurov, Т. S. Teptsova | ||
"... of the therapy regimen including ticagrelor in combination with ASA on the target indicators of the State Health ..." | ||
Vol 16, No 4 (2023) | Possibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis | Abstract similar documents |
A. Yu. Ovchinnikov, N. A. Miroshnichenko, Yu. O. Nikolaeva | ||
"... Background. There are numerous diagnostic methods and therapy regimens for chronic tonsillitis (CT ..." | ||
Vol 12, No 1 (2019) | Individual cost accounting in the management of medical organizations | Abstract similar documents |
I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali | ||
"... видам деятельности и ее модификации Time-driven ABC (TDABS), а также возможность их адаптации для ..." | ||
Vol 16, No 4 (2023) | Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma | Abstract similar documents |
S. K. Zyryanov, K. V. Orlova | ||
"... a regimen with BRAF/MEK inhibitors as the first line and prolgolimab as the second line in adult patients ..." | ||
Vol 14, No 2 (2021) | Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis | Abstract similar documents |
N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova | ||
"... chemotherapy regimens in the treatment of MDR/XDR-TB. Numerous studies have shown that, from a clinical point ..." | ||
Vol 17, No 2 (2024) | Mathematical modeling and analysis of export trends for certain pharmaceutical groups | Abstract similar documents |
А. R. Shaikhislamova, N. А. Gasratova | ||
"... Background. The analysis of the exports of medicines of the Russian Federation (RF) by group 30 ..." | ||
Vol 18, No 2 (2025) | Cosmetics as a product group of the Russian pharmaceutical market: analysis of competition and level of dominance | Abstract similar documents |
N. I. Markov, L. S. Treshchetkina | ||
"... published by DSM Group. The analysis employed the Linda index and the Herfindahl–Hirschman Index (HHI ..." | ||
Vol 13, No 3 (2020) | The review of the foreign experience on the financing of innovative medical technologies | Abstract similar documents |
V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev | ||
"... -related groups (DRG) does not contribute to the implementation of innovations in the medical practice ..." | ||
Vol 18, No 1 (2025) | Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia | Abstract similar documents |
A. Yu. Efremov, A. M. Vlasov, V. I. Gegechkori, N. V. Gorpinchenko, G. V. Ramenskaya, T. M. Litvinova | ||
"... and marketing methods, including normalization of drug costs to weighted average prices (rub/mg), ABC analysis ..." | ||
Vol 12, No 2 (2019) | Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria | Abstract similar documents |
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova | ||
"... the alternative treatment regimens by 34.5-229.5 thousand rubles or 13.12-50.14%. According to the cost ..." | ||
Vol 14, No 2 (2021) | Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price | Abstract similar documents |
D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov | ||
"... study was performed to compare active platinum-containing chemotherapy regimens of the first line ..." | ||
Vol 16, No 3 (2023) | Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region | Abstract similar documents |
A. D. Ermolaeva, T. N. Ermolaeva, K. A. Kokushkin | ||
"... standard treatment regimens to quadritherapy, including in combination with a drug of the angiotensin ..." | ||
Vol 16, No 4 (2023) | Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C | Abstract similar documents |
I. A. Narkevich, E. A. Tsitlionok | ||
"... diagnosis of chronic hepatitis C. The first line therapy regimens were analyzed and compared ..." | ||
Vol 8, No 1 (2015) | PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
L. S. Melnikova | ||
Vol 10, No 3 (2017) | The strategies of drug supply for patients with chronic hepatitis C | Abstract similar documents |
E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin | ||
Vol 17, No 2 (2024) | Methodology of forming a model of diagnosis-related groups for cases of medical care using surgery performed by laparoscopic access | Abstract similar documents |
I. A. Zheleznyakova, O. A. Volkova, E. I. Rumiantseva, I. A. Mikhailov, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, T. S. Vakhrusheva, E. S. Samsonova, V. V. Omelyanovskiy | ||
"... of diagnosis-related groups (DRGs) for cases of surgical medical care provided by laparoscopic access ..." | ||
Vol 17, No 4 (2024) | Pharmacoeconomic study of active psoriatic arthritis treatment | Abstract similar documents |
A. V. Rudakova, Т. V. Korotaeva | ||
"... evaluated regimens when using netakimab. For comparators, the costs to achieve an additional case ..." | ||
Vol 10, No 4 (2017) | THE STATE GUARANTEES PROGRAM OF FREE MEDICAL CARE: APPROACHES TO STANDARDIZE THE COSTS OF MEDICAL CARE | Abstract similar documents |
Yu. A. Ledovskikh, E. V. Semakova, M. V. Avksent’eva | ||
"... and statistical groups. ..." | ||
Vol 11, No 2 (2018) | Introduction of medical products into healthcare practice and costs reimbursement: European experience | Abstract similar documents |
V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii | ||
Vol 16, No 2 (2023) | Methodological approach to the formation of the list of high-tech medical care types | Abstract similar documents |
I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy | ||
"... groups (DRGs), on the one hand, significantly expanded the availability of HTMC methods ..." | ||
1 - 50 of 197 Items | 1 2 3 4 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)